Role Summary
We are seeking a highly motivated Senior Accountant to join our growing team. As Senior Accountant, you will be the primary preparer of most accounting workpapers and support, reporting to the Associate Director/Director of Accounting and SEC Reporting and working closely with the AP Manager. This is an exciting opportunity to contribute to the advancement of cutting-edge medical treatments and shape the future of healthcare.
We welcome applications from candidates located across the Northeast and Mid-Atlantic.
Primary Responsibilities
- Participate in the monthly and annual accounting closing processes and contribute to producing accurate and timely financial statements
- Prepare all recurring monthly journal entries
- Maintain all balance sheet reconciliations and update monthly to ensure accurate reporting
- Provide detailed fluctuation analysis for month end closing
- Maintain effective internal controls and prepare annual internal control process narratives and key control analysis
- Assist AP Manager in proper coding of invoices
- Ensure financial records are maintained in compliance with GAAP
- Support financial statement audits and reports
- Collaboration with operational personnel on financial and operational matters
- Special projects and other assignments as required
Required Skills and Qualifications
- BA/BS degree in Accounting or related field
- 3-5 years of experience in an Accounting role
- Ability to work effectively with all levels of an organization
- Strong analytical skills with a high level of accuracy and attention to detail
- Ability to manage competing priorities and deadlines and strong problem-solving skills
- Strong written and verbal communication
- Intermediate or Advanced aptitude in Excel is required
- CPA or equivalent (or on-track) preferred
- Experience with a Big 4 or national firm, SEC registered company and/or Biotech company is preferred
- Familiarity with NetSuite and FloQast a plus
- Ability to travel to HQ quarterly
About Lexeo
Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
Top Skills
What We Do
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central nervous system diseases affecting both larger-rare and prevalent patient populations. LEXEO’s foundational science stems from partnerships and exclusive licenses with leading academic laboratories at Weill Cornell Medical College and the University of California, San Diego, two preeminent institutions on the cutting edge of gene therapy research. LEXEO is advancing a deep and diverse pipeline of AAV-based gene therapy candidates in rare cardiovascular diseases, APOE4-associated Alzheimer’s disease, and CLN2 Batten disease, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.
